Please login to the form below

Not currently logged in
Email:
Password:

Pfizer strengthens board of directors

Ronald Blaylock brings financial and business leadership expertise

Pfizer Ronald BlaylockPfizer has bolstered its board of directors with the appointment of Ronald Blaylock, who joins with immediate effect.

Blaylock currently serves as managing partner of private equity firm GenNx360 Capital Partners, which he founded in 2006.

Prior to this, he founded investment banking firm Blaylock & Company in 1993, subsequently serving as chairman and chief executive officer.

He brings further senior management experience from Paine Webber and CitiGroup, and currently serves on the boards of CarMax, Radio One, WR Berkley and Syncreon.

Ian Read, Pfizer's chairman and chief executive officer, said: “We are pleased to welcome Ron Blaylock to Pfizer's board of directors.

“He brings business, financial and leadership expertise, which will be an asset to Pfizer's diverse board and to our company. The addition of Ron to our board helps to ensure that Pfizer continues to benefit from a breadth and variety of experience.”

28th February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics